Literature DB >> 9599365

Radiation therapy for uveal malignant melanoma.

C L Shields1, J A Shields, K Gündüz, J E Freire, G Mercado.   

Abstract

The treatment of uveal melanoma is controversial. The treatment methods include enucleation and other techniques designed to preserve the eye, such as local resection, plaque radiotherapy, charged particle radiotherapy, laser photocoagulation, and thermotherapy. Plaque radiotherapy and charged particle radiotherapy provide tumor control and patient survival comparable with enucleation. Plaque radiotherapy may be associated with fewer anterior segment complications, but the posterior segment complications appear to be similar using either plaque radiotherapy or charged particle radiotherapy. Thermotherapy is emerging as an important adjuvant treatment to maintain control of uveal melanoma after radiotherapy.

Entities:  

Mesh:

Year:  1998        PMID: 9599365

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  7 in total

1.  Ruthenium-106 plaque radiotherapy alone or in combination with transpupillary thermotherapy in the management of choroidal melanoma.

Authors:  Kaan Gündüz; Rengin Aslihan Kurt; Hale Elif Akmeşe; Kenan Köse; Omür Uçakhan-Gündüz
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

2.  Vasoproliferative tumours of the retina.

Authors:  H Heimann; N Bornfeld; O Vij; S E Coupland; N E Bechrakis; U Kellner; M H Foerster
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 3.  Retinoblastoma and vision.

Authors:  Omar Warda; Zishan Naeem; Kelsey A Roelofs; Mandeep S Sagoo; M Ashwin Reddy
Journal:  Eye (Lond)       Date:  2022-01-05       Impact factor: 3.775

4.  Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma.

Authors:  Tahra AlMahmoud; Sean Quinlan-Davidson; Gregory R Pond; Jean Deschênes
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Apr-Jun

5.  Outpatient ocular brachytherapy: The USC Experience.

Authors:  Sarah Joh; Mary E Kim; Michael Reilly; Sue Y Zhou; Jonathan Kim; Richard L Jennelle; Jesse L Berry
Journal:  Adv Radiat Oncol       Date:  2021-06-11

6.  Bevacizumab and intraocular tumors: an intriguing paradox.

Authors:  Mariam el Filali; Long V Ly; Gregorius P M Luyten; Mieke Versluis; Hans E Grossniklaus; Pieter A van der Velden; Martine J Jager
Journal:  Mol Vis       Date:  2012-10-05       Impact factor: 2.367

Review 7.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.